Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases.
Martina MG, Giorgio C, Allodi M, Palese S, Barocelli E, Ballabeni V, Szpakowska M, Chevigné A, Piet van Hamburg J, Davelaar N, Lubberts E, Bertoni S, Radi M.
Martina MG, et al. Among authors: bertoni s.
Eur J Med Chem. 2022 Dec 5;243:114703. doi: 10.1016/j.ejmech.2022.114703. Epub 2022 Aug 29.
Eur J Med Chem. 2022.
PMID: 36067700